These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32 related articles for article (PubMed ID: 32817951)
1. Discovery of Clioquinol and Analogues as Novel Inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection, ACE2 and ACE2 - Spike Protein Interaction Olaleye OA; Kaur M; Onyenaka C; Adebusuyi T bioRxiv; 2020 Aug; ():. PubMed ID: 32817951 [TBL] [Abstract][Full Text] [Related]
2. Discovery of Clioquinol and analogues as novel inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 infection, ACE2 and ACE2 - Spike protein interaction Olaleye OA; Kaur M; Onyenaka C; Adebusuyi T Heliyon; 2021 Mar; 7(3):e06426. PubMed ID: 33732940 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory mechanism of clioquinol and its derivatives at the exopeptidase site of human angiotensin-converting enzyme-2 and receptor binding domain of SARS-CoV-2 viral spike. Kehinde IA; Egbeyemi A; Kaur M; Onyenaka C; Adebusuyi T; Olaleye OA J Biomol Struct Dyn; 2023 Apr; 41(7):2992-3001. PubMed ID: 35220925 [TBL] [Abstract][Full Text] [Related]
4. Ambroxol Hydrochloride Inhibits the Interaction between Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein's Receptor Binding Domain and Recombinant Human ACE2. Olaleye OA; Kaur M; Onyenaka CC bioRxiv; 2020 Sep; ():. PubMed ID: 32995775 [TBL] [Abstract][Full Text] [Related]
5. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection. Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306 [TBL] [Abstract][Full Text] [Related]
6. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity. Zhu Y; Yu D; Yan H; Chong H; He Y J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627 [TBL] [Abstract][Full Text] [Related]
7. Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex. Laurini E; Marson D; Aulic S; Fermeglia M; Pricl S ACS Nano; 2020 Sep; 14(9):11821-11830. PubMed ID: 32833435 [TBL] [Abstract][Full Text] [Related]
8. Blocking Effect of Demethylzeylasteral on the Interaction between Human ACE2 Protein and SARS-CoV-2 RBD Protein Discovered Using SPR Technology. Zhu ZL; Qiu XD; Wu S; Liu YT; Zhao T; Sun ZH; Li ZR; Shan GZ Molecules; 2020 Dec; 26(1):. PubMed ID: 33374387 [TBL] [Abstract][Full Text] [Related]
9. Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and mammals. Hayashi T; Abiko K; Mandai M; Yaegashi N; Konishi I Vet Q; 2020 Dec; 40(1):243-249. PubMed ID: 32921279 [TBL] [Abstract][Full Text] [Related]
10. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Yang J; Wang W; Chen Z; Lu S; Yang F; Bi Z; Bao L; Mo F; Li X; Huang Y; Hong W; Yang Y; Zhao Y; Ye F; Lin S; Deng W; Chen H; Lei H; Zhang Z; Luo M; Gao H; Zheng Y; Gong Y; Jiang X; Xu Y; Lv Q; Li D; Wang M; Li F; Wang S; Wang G; Yu P; Qu Y; Yang L; Deng H; Tong A; Li J; Wang Z; Yang J; Shen G; Zhao Z; Li Y; Luo J; Liu H; Yu W; Yang M; Xu J; Wang J; Li H; Wang H; Kuang D; Lin P; Hu Z; Guo W; Cheng W; He Y; Song X; Chen C; Xue Z; Yao S; Chen L; Ma X; Chen S; Gou M; Huang W; Wang Y; Fan C; Tian Z; Shi M; Wang FS; Dai L; Wu M; Li G; Wang G; Peng Y; Qian Z; Huang C; Lau JY; Yang Z; Wei Y; Cen X; Peng X; Qin C; Zhang K; Lu G; Wei X Nature; 2020 Oct; 586(7830):572-577. PubMed ID: 32726802 [TBL] [Abstract][Full Text] [Related]
11. A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor. Souza PFN; Lopes FES; Amaral JL; Freitas CDT; Oliveira JTA Int J Biol Macromol; 2020 Dec; 164():66-76. PubMed ID: 32693122 [TBL] [Abstract][Full Text] [Related]
12. A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2). Lee JH; Choi M; Jung Y; Lee SK; Lee CS; Kim J; Kim J; Kim NH; Kim BT; Kim HG Biosens Bioelectron; 2021 Jan; 171():112715. PubMed ID: 33099241 [TBL] [Abstract][Full Text] [Related]
13. Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana. Rattanapisit K; Shanmugaraj B; Manopwisedjaroen S; Purwono PB; Siriwattananon K; Khorattanakulchai N; Hanittinan O; Boonyayothin W; Thitithanyanont A; Smith DR; Phoolcharoen W Sci Rep; 2020 Oct; 10(1):17698. PubMed ID: 33077899 [TBL] [Abstract][Full Text] [Related]
14. Identification of a repurposed drug as an inhibitor of Spike protein of human coronavirus SARS-CoV-2 by computational methods. Unni S; Aouti S; Thiyagarajan S; Padmanabhan B J Biosci; 2020; 45(1):. PubMed ID: 33184246 [TBL] [Abstract][Full Text] [Related]
15. Quercetin and Its Metabolites Inhibit Recombinant Human Angiotensin-Converting Enzyme 2 (ACE2) Activity. Liu X; Raghuvanshi R; Ceylan FD; Bolling BW J Agric Food Chem; 2020 Nov; 68(47):13982-13989. PubMed ID: 33179911 [TBL] [Abstract][Full Text] [Related]
16. Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells. Baig MS; Alagumuthu M; Rajpoot S; Saqib U Drugs R D; 2020 Sep; 20(3):161-169. PubMed ID: 32592145 [TBL] [Abstract][Full Text] [Related]
17. Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor. Hati S; Bhattacharyya S ACS Omega; 2020 Jul; 5(26):16292-16298. PubMed ID: 32656452 [TBL] [Abstract][Full Text] [Related]
18. Utilization of SUMO Tag and Freeze-thawing Method for a High-level Expression and Solubilization of Recombinant Human Angiotensinconverting Enzyme 2 (rhACE2) Protein in Mohammadi M; Taheri RA; Bemani P; Hashemzadeh MS; Farnoosh G; Amini R Protein Pept Lett; 2022; 29(7):605-610. PubMed ID: 35838231 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and Biological Evaluation of Umifenovir Analogues as Anti-SARS-CoV-2 Agents. Tanaka H; Miyagi S; Yoshida Y; Lamb JS; Chick CN; Luhata LP; Shibata M; Tanaka E; Suzuki Y; Usuki T ChemistrySelect; 2022 Aug; 7(30):e202202097. PubMed ID: 36245851 [TBL] [Abstract][Full Text] [Related]
20. Techniques used for the discovery of therapeutic compounds: The case of SARS. Chen S; Chen L; Chen K; Shen X; Jiang H Drug Discov Today Technol; 2006; 3(3):277-83. PubMed ID: 24980529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]